Abstract:Heart growth is tightly controlled so that the heart reaches a predetermined size. Fetal heart growth occurs through cardiomyocyte proliferation, whereas postnatal heart growth involves primarily physiological cardiomyocyte hypertrophy. The Hippo kinase cascade is an important regulator of organ growth. A major target of this kinase cascade is YAP1, a transcriptional coactivator that is inactivated by Hippo kinase activity. Here, we used both genetic gain and loss of Yap1 function to investigate its role in regulating proliferative and physiologic hypertrophic heart growth. Fetal Yap1 inactivation caused marked, lethal myocardial hypoplasia and decreased cardiomyocyte proliferation, whereas fetal activation of YAP1 stimulated cardiomyocyte proliferation. Enhanced proliferation was particularly dramatic in trabecular cardiomyocytes that normally exit from the cell cycle. Remarkably, YAP1 activation was sufficient to stimulate proliferation of postnatal cardiomyocytes, both in culture and in the intact heart. A dominant negative peptide that blocked YAP1 binding to TEAD transcription factors inhibited YAP1 proliferative activity, indicating that this activity requires YAP1-TEAD interaction. Although Yap1 was a critical regulator of cardiomyocyte proliferation, it did not influence physiological hypertrophic growth of cardiomyocytes, because postnatal Yap1 gain or loss of function did not significantly alter cardiomyocyte size. These studies demonstrate that Yap1 is a crucial regulator of cardiomyocyte proliferation, cardiac morphogenesis, and myocardial trabeculation. Activation of Yap1 in postnatal cardiomyocytes may be a useful strategy to stimulate cardiomyocyte expansion in therapeutic myocardial regeneration.

Yap1 Regulates Multiple Steps of Chondrocyte Differentiation during Skeletal Development and Bone Repair

Reciprocal Inhibition of YAP/TAZ and NF-κB Regulates Osteoarthritic Cartilage Degradation

Control of skeletal morphogenesis by the Hippo-YAP/TAZ pathway

YAP1 Negatively Regulates Chondrocyte Differentiation Partly by Activating the Β-Catenin Signaling Pathway.

Hippo/YAP1 promotes osteoporotic mice bone defect repair via the activating of Wnt signaling pathway

YAP1 is Essential for Osteoclastogenesis Through a TEADs-dependent Mechanism

YAP promotes osteogenesis and suppresses adipogenic differentiation by regulating β-catenin signaling

YAP-mediated regulation of the chondrogenic phenotype in response to matrix elasticity

A Coordinated Phosphorylation By Lats And Ck1 Regulates Yap Stability Through Scf Beta-Trcp

Downregulation of Yap1 during limb regeneration results in defective bone formation in axolotl

Inactivation of Yap Oncoprotein by the Hippo Pathway is Involved in Cell Contact Inhibition and Tissue Growth Control

Yap 1 regulates vascular smooth muscle cell phenotypic switch by interaction with myocardin

Structural and functional insights into the TEAD-YAP complex in the Hippo signaling pathway

Yap1, the Nuclear Target of Hippo Signaling, Stimulates Heart Growth Through Cardiomyocyte Proliferation but Not Hypertrophy

Integration of Mechanical and Chemical Signals by YAP and TAZ Transcription Coactivators.

Harness the power: new insights into the inhibition of YAP/Yorkie.

Inhibition of YAP with siRNA prevents cartilage degradation and ameliorates osteoarthritis development

The Role of YAP Transcription Coactivator in Regulating Stem Cell Self-Renewal and Differentiation.

TEAD Mediates YAP-dependent Gene Induction and Growth Control

YAP1 Inhibits the Induction of TNF‐α‐stimulated Bone‐resorbing Mediators by Suppressing the NF‐κB Signaling Pathway in MC3T3‐E1 Cells

Yap and Taz promote osteogenesis and prevent chondrogenesis in neural crest cells in vitro and in vivo